Uncategorized
LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station
FARMINGTON, Conn.--(BUSINESS WIRE)--LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineering partner Space Tango on Northrop Grumman’s 14th Commercial Resupply Services Mission for NASA (NG-14) to the International Space Station (ISS) U.S. National Laboratory. Scheduled to launch on September 30th at 2:26 UTC (10:26 p.m. ET), NG-14 is the first of a series of NASA flights to the ISS in low-Earth orb